The synergistic interactions of oleoyl-lysophosphatidic acid in platelet aggregation

Medical Science Research

Volumn 27, Issue 7, 1999, Pages 435-441

  Nugent, Desmond ^a   Belinson, Jerome L ^b   Xu, Yan ^a,b  

^a Department of Cancer Biology ^*  (Ireland)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

ADP; Arachidonic acid; Ionophore A23,187; Lysophosphatidic acid; Noradrenaline phorbol 12 myristate 13 acetate; Platelet aggregation; Sodium fluoride; Thrombin receptor agonist peptide

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CALCIMYCIN; FATTY ACID; FLUORIDE SODIUM; LYSOPHOSPHATIDIC ACID; MEMBRANE RECEPTOR; NORADRENALIN; OLEOYLLYSOPHOSPHATIDIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; THROMBIN RECEPTOR ACTIVATING PEPTIDE; THROMBOXANE A2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN CELL; HUMAN EXPERIMENT; MALE; NONHUMAN; NORMAL HUMAN; THROMBOCYTE AGGREGATION;

EID: 0032778246     PISSN: 02698951     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger. J Biol Chem 1995; 270:12949-12952.
2. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC. Lysophosphatidic acid: G-protein signaling and cellular responses. Curr Opin Cell Biol 1997; 9:168-173.
3. Mauco G, Chap H, Simon MF, Douste-Blazy L. Phosphatidic and lysophosphatidic acid production in phospholipase C- and thrombintreated platelets. Possible involvement of a platelet lipase. Biochimie 1978; 60:653-661.
4. Watson SP, McConnell RT, Lapetina EG. Decanoyl lysophosphatidic acid induces platelet aggregation through an extracellular action. Evidence against a second messenger role of lysophosphatidic acid. BiochemJ 1985; 232:61-66.
5. Gerrard JM, Robinson P. Identification of the molecular species of lysophosphatidic acid produced in thrombin stimulated platelets. Biochim Biophys Acta 1989; 1001:282-285.
6. Fukami K, Takenawa T. Phosphatidic acid that accumulates in plateletderived growth factor-stimulated Balb/c 3T3 cells is a potential mitogenic signal. J Biol Chem 1992; 267:10988-10993.
7. Eichholtz T, Jalink K, Fahrenfort I, Moolenaar WH. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J 1993; 291:677-680.
8. Nietgen GW, Chan CK, Durieux ME. Inhibition of lysophosphatidate signaling by lidocaine and bupivacaine. Anesthesiology 1997; 86:1112-1119.
9. Schumacher KA, Classen HG, Spath M. Platelet aggregation evoked in vitro and in vivo by phosphatidic acids and lysoderivatives: identity with substances in aged serum (DAS). Thromb Haemost 1979; 42:631-640.
10. Gerrard JM, Kindom SE, Peterson DA, Peller J, Krantz KE, White JG. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux. Am J Pathol 1979; 96:423138.
11. Ikeda Y, Kikuchi M, Toyama K, Watanabe K, Ando Y. lonophoretic activities of phospholipids on human platelets. Thromb Haemost 1979; 41:779-786.
12. Tokumura A, Fukuzawa K, Isobe J, Tsukatani H. Lysophosphatidic acid-induced aggregation of human and feline platelets: Structureactivity relationship. Biochem Biophvs Res Commun 1981; 99:391-398.
13. Benton AM, Gerrard JM, Kindom SE. Are lysophosphatidic acids or phosphatidic acid involved in stimulus activation coupling in platelets? Blood 1982; 60:642-649.
14. Simon MF, Chap H, Douste-Blazy L. Human platelet aggregation induced by 1 -alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem Biophys Res Commun 1982; 108:1743-1750.
15. Gerrard JM, Kindom SE, Peterson DA, White JG. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets. Am J Pathol 1979:97:531-547.
16. Huang EMH, Detwiler TC. Characteristics of the synergistic actions of platelet agonists. Blood 1981; 57:685-691.
17. DeMinno G, Silver MJ, Murphy S. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents. Blood 1982; 59:563-568.
18. Steen VM, Holmsen H. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion. Thromb Haemost 1985; 54:680-683.
19. Sturk A, Asyee GM, Schaap MC, van Maanen M, Cate JW. Synergistic effects of platelet activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. Thromb Res 1985; 40:359-372.
20. Chaffoy de Courcelles D, Roevens P, van Belle H, de Clerck F. The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction. FEES Lett 1987; 219:283-288.
21. Sugiura T, Tokumura A, Gregory L. Nouchi T, Weintraub ST, and Hanahan DJ. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor. Arch Biochem Biophys 1994; 31:358-368.
22. Holmsen H. Significance of testing platelet function in vitro. Eur J Clin Invest 1994; 24:3-8.
23. Nugent DF, Dinan TG, Leonard BE. Alteration by a plasma factor(s) of platelet aggregation in unmedicated unipolar depressed patients. J Affect Disord 1994; 31:61-66.
24. Peters JRR, Grahame-Smith DG. Human platelet 5HT receptors: characterisation and functional association. Eur J Pharmacol 1980; 68:243-256.
25. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962; 162:67-68.
26. Nugent DF, Dinan TG, Leonard BE. Further characterisation of the inhibition of platelet aggregation by a plasma factor(s) in unmedicated unipolar depressed patients. J Affect Disord 1998; 33:227-231.
27. Kienast J, Arnout J, Pfiegler G, Deckmyn H, Hioet B, Vermylen D. Sodium fluoride mimics effects of both agonists and antagonists on intact human platelets by simultaneous modulation of phospholipase C and adenylate cyclase activity. Blood 1987; 69:859-866.
28. Kroll WH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989:74:1181-1195.
29. Brass LF, Hoxie JA, Kieber-Emmons T, Manning DR, Poncz M, Woolkalis M. Agonist receptors and G protein as mediator of platelet activation. In: Mechanisms of Platelet Activation and Control. New York: Plenum Press; 1993. pp. 17-36.
30. Brass LF, Manning DR, Cichowski K, Abrams CS. Signaling through G protein in platelets: to the integrins and beyond. Thromb Haemost 1997; 78:581-589.
31. Maclntyre DE, McNicol A, Drummond AH. Tumour promoting phorbol esters inhibits agonist induced phosphatidate formation and Ca2flux in human platelets. FEES Lett 1985; 180:160-164.
32. Yatomi Y, Yamamura S, Ruan F, Igarashi Y. Sphingosine 1-phosphate induced platelet activation through an extracellular action and shares a platelet surface receptor with lysophosphatidic acid. J Biol Chem 1997; 272:5291-5297.
33. Hecht JH, Weiner JA, Post SR, Chun J. Ventricular Zone Gene-1 (vzgI) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex. J Cell Biol 1996; 135:1071-1083.
34. Guo Z, Liliom K, Fischer DJ, Bathurst 1C, Tomei LD, Kiefer MC, et al. Molecular cloning of a high-affinity receptor for the growth factor-like lipid mediator lysophosphatidic acid from Xenopus oocytes. Proc Natl AcadSci USA 1996; 93:14367-14372.
35. An S, Dickens MA, Bleu T, Hallmark OG, Goetzl EJ. Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid. Biochem Biophys Res Commun 1997; 231:619-622.
36. An S, Bleu T, Hallmark OG, Goetzl EJ. Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid, J Biol Chem 1998; 273:7906-7910.
37. Bigay J, Déterre P. Pfister C, Chabre M. Fluoride complexes of aluminium or beryllium act on G-proteins as reversibly bound analogues of the gamma phosphate of GTP. EMBO J 1987; 6:2907-2913.
38. Cachet C, Cattaneo M, Ohlmann P, Hechler B, Leech A, Chevalier J, et al. Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors. Br J Haematol 1995; 91:434-444.
39. Hourani SM. Purinoreceptors and platelet aggregation. J Auton Pharmacol 1996; 16:349-352.
40. Puri RN, Colman RW. Purinergic receptors in human blood platelets: chemical modification and cloning investigations. J Protein Chem 1998; 17:429-451.
41. Simon MF, Chap H, Douste-Blazy L. Platelet aggregating activity of lysophosphatidic acids is not related to their calcium ionophore properties. FEBSLett 1984; 166:115-119.